The company is now reportedly planning to offer 7 million shares at a price range of $24 to $25, up from the original planned offering of 6 million shares at $20 to $23. As such, the total amount raised could increase from approximately $129 million to $172 million.
The company will be traded on the Nasdaq stock market under the symbol HCAT. It is expected to go public on July 25.
More articles on data analytics:
Healthcare software company Phreesia goes public: 3 things to know
Atrium Health deploys automation, data analytics for medication management
How Johns Hopkins boosted data sharing between patients, clinicians: CMIO Dr. Peter Greene
